Some New York hospitals and nonprofit healthcare organizations say a change in the way the state manages the 340B prescription drug program could lead to losses of up to 300 jobs and $30 million, Buffalo Business First reported Feb 8.
Read the full post on Becker's Hospital Review - Healthcare News
